Overview

Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy of albumin infusion to prevent post tips hepatic encephalopathy'
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Roma La Sapienza
Criteria
Inclusion Criteria:

- Cirrhotic patients

- TIPS placement

- Absence of Hepatic Encephalopathy at the enrolement

- Age > 18 years

- No pregnancy

Exclusion Criteria:

- Non-cirrhotic portal hypertension

- Previous liver transplantation

- Impossibility to attend the scheduled follow-up including the weekly visit as
outpatients during the first month after TIPS (see the description of follow-up below)

- Sings of overt hepatic encephalopathy as well as a history of persistent HE at entry.
The latter as a contraindication for TIPS placement